GR

Grifols

- NASDAQ:GRFS
Last Updated 2021-09-21

LinkedIn Profile

Access Grifols historical Linkedin company profile data on number of followers, employee headcount and more
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Sector Industry
nasdaq:grfs 16940 Aug 11th, 2021 12:00AM Grifols 152K 9143 Open Pharmaceuticals Aug 10th, 2021 10:51PM Aug 10th, 2021 10:51PM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174
nasdaq:grfs 16940 Aug 10th, 2021 12:00AM Grifols 152K 9144 Open Pharmaceuticals Aug 10th, 2021 10:19AM Aug 10th, 2021 10:19AM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174
nasdaq:grfs 16940 Aug 9th, 2021 12:00AM Grifols 152K 9144 Open Pharmaceuticals Aug 9th, 2021 09:18AM Aug 9th, 2021 09:18AM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174
nasdaq:grfs 16940 Aug 8th, 2021 12:00AM Grifols 152K 9137 Open Pharmaceuticals Aug 8th, 2021 06:09PM Aug 8th, 2021 06:09PM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174
nasdaq:grfs 16940 Aug 7th, 2021 12:00AM Grifols 152K 9134 Open Pharmaceuticals Aug 6th, 2021 10:39PM Aug 7th, 2021 05:01PM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174
nasdaq:grfs 16940 Aug 6th, 2021 12:00AM Grifols 152K 9133 Open Pharmaceuticals Aug 6th, 2021 09:21AM Aug 6th, 2021 09:21AM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174
nasdaq:grfs 16940 Aug 5th, 2021 12:00AM Grifols 152K 9133 Open Pharmaceuticals Aug 5th, 2021 12:20AM Aug 5th, 2021 12:18PM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174
nasdaq:grfs 16940 Aug 4th, 2021 12:00AM Grifols 152K 9132 Open Pharmaceuticals Aug 4th, 2021 09:10AM Aug 4th, 2021 09:10AM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174
nasdaq:grfs 16940 Aug 3rd, 2021 12:00AM Grifols 152K 9132 Open Pharmaceuticals Aug 3rd, 2021 09:02AM Aug 3rd, 2021 09:02AM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174
nasdaq:grfs 16940 Aug 2nd, 2021 12:00AM Grifols 152K 9140 Open Pharmaceuticals Aug 2nd, 2021 10:26AM Aug 2nd, 2021 10:26AM Grifols is a global healthcare company which, since its foundation in Barcelona in 1909, has been working to improve the health and well-being of people all over the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative medicines, solutions and services in more than 100 countries and regions. As a pioneer in the blood products industry, we are one of the largest plasma companies, with a growing network of donation centers around the world. With the plasma we obtain, we produce essential medicines to treat chronic, rare and sometimes life-threatening diseases. As a recognized leader in transfusion medicine, we have a comprehensive portfolio of solutions designed to ensure safety from donation to transfusion. In addition, we provide hospitals, pharmacies and healthcare professionals with diagnostic tools and services that help improve the detection and treatment of diseases, promoting specialized and efficient care. Our commitment to science and people drives us day after day to continue innovating and exploring the potential of plasma treatments to respond to the main health challenges facing our society. With a workforce of over 24,000 employees in more than 30 countries and regions, Grifols is committed to a sustainable business model and is a pioneer in continuous innovation, quality, safety and ethical leadership in the healthcare sector. Our work has a positive social and economic impact in the countries where we operate, creating jobs and generating wealth. Open Plasmapheresis, Plasma derived therapies, Diagnostics, Intravenous therapies, Clinical nutrition, Automate drug compounding , Drug inventory control, Healthcare Open Parc Empresarial Can Sant Joan, Av. de la Generalitat, 152-158 Sant Cugat del Vallès Barcelona ES 08174

Request a demo to view additional historical data, and much more.

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.